Kenichi Inoue

9PUBLICATIONS
25CO-AUTHORS
Molecular targetsPacific Peoples nursingPredictive and prognostic markersOccupational epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 06, 2023
Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial.

Ian E Krop, Norikazu Masuda, Toru Mukohara

|Jul 30, 2022
Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study.

Haruru Kotani, Norikazu Masuda, Toshinari Yamashita

|Jul 16, 2021
Perceptions of Japanese and Dutch women with early breast cancer about monitoring their quality of life.

Rieneke T Lugtenberg, Adrian Kaptein, Ayako Matsuda

|Mar 13, 2020
Illness Perceptions and Quality of Life in Patients with Non-Small-Cell Lung Cancer: A 3-Month Follow-Up Pilot Study.

Manja Vollmann, Ayako Matsuda, Judith R Kroep

|Jan 18, 2020
Effectiveness and safety of eribulin in Japanese patients with HER2-negative, advanced breast cancer: a 2-year post-marketing observational study in a real-world setting.

Kenichi Inoue, Masato Takahashi, Hirofumi Mukai

|Jul 11, 2019
TS-1 add-on therapy in Japanese patients with triple-negative breast cancer after neoadjuvant or adjuvant chemotherapy: a feasibility study.

Kenichi Inoue, Shigenori E Nagai, Tsuyoshi Saito

Pageof 2

Frequent Collaborators

2 joint publications

Judith R Kroep

2 joint publications

Johannes W R Nortier

2 joint publications

Maarten J Fischer

2 joint publications

Adrian Kaptein